跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL VINCRISTINE SULFATE 2mg/2mL Injection Vial - TGA Drug Approval Details
Approvals
/
TGA
/
DBL VINCRISTINE SULFATE 2mg/2mL Injection Vial
Approved
STANDARD
DBL VINCRISTINE SULFATE 2mg/2mL Injection Vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
8e7df1b1867455a6
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
8e7df1b1867455a6
Product Name
DBL VINCRISTINE SULFATE 2mg/2mL Injection Vial
Artg Id
47249
Artg Name
DBL VINCRISTINE SULFATE 2mg/2mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-01-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/94e8c59edfaae498acbe08a5e7c5f38b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/0996b9a5f864de17a95d2552b35eb322.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
8e7df1b1867455a6
Type
Standard
Back to TGA Approvals